Last reviewed · How we verify
CRS3123
At a glance
| Generic name | CRS3123 |
|---|---|
| Sponsor | Crestone, Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection (PHASE2)
- Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants (PHASE1)
- Phase I Trial of a Single Dose of CRS3123 (PHASE1)
- Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CRS3123 CI brief — competitive landscape report
- CRS3123 updates RSS · CI watch RSS
- Crestone, Inc portfolio CI